Today is #WorldMSDay !

We stand in solidarity with MS Int'l Federation and everyone affected by #MultipleSclerosis who is advocating for the early and accurate diagnosis of the condition.

#MyMSDiagnosis

#UnitedWeStand with patients around the world living with Inflammatory Bowel Disease. Let's come together to raise awareness about this chronic condition that affects millions of people worldwide. #IBDHasNoBorders #EqualIBDCare

Last week, Axios convened policy experts and advocates for a solutions-oriented roundtable discussion presented by Sandoz to discuss the ongoing generic drug shortage issues in the US.

Read more: axios.com/2024/05/10/axi…

#Generics #DrugShortages

Sandoz is joining the Energize Program as a sponsor! This first-of-its-kind program fosters collaboration between leading pharmaceutical companies and their suppliers to mitigate the overall environmental impact of the industry – and represents another important step on our

Rebecca Guntern, President Region Europe, & Peter Stenico, Global Head of Biosimilars, spoke Reuters Events Pharma about how revised pharma legislation can help improve patient access to medicines and drive health equity.🌍

#REPharma2024 #Biosimilars #Generics

How can EU pharma legislation be reviewed to promote timely, equitable & expanded access to high-quality & affordable #generics & #biosimilars ?📈

This is one of the topics we are discussing at this year’s Reuters Events Pharma.

Follow us for more updates!

#Healthcare #REPharma2024

Heading to the Festival of Biologics USA in San Diego next week? 📅

Sonia Oskouei, our VP of #Biosimilars and Specialty, will be on stage to discuss a roadmap to a sustainable US biosimilar market.

#FestivalOfBiologics #FestivalOfBiologics USA

Democratizing access to biologics is central to how we help shape the future of healthcare. Learn more in our 2023 annual report: annualreport.sandoz.com

The #BeneathTheSurface study is live! Learn more about what Medicines for Europe discovered about the societal value of #GenericMedicines in four dimensions: economic, patient access, supply chain security, and innovation.

iqvia.com/-/media/iqvia/…

#AccessForAll #Generics

Novel ways of delivering on our Purpose drive our financial results. A healthy growth rate in our sales in 2023 shows that we are on the right track to expand our business. Read more from our 2023 annual report: annualreport.sandoz.com/#novel_ways

Save the date and register! On April 10 Medicines for Europe will present the new study #BeneathTheSurface to bring to light long-term benefits that #generics provide to the entire healthcare system beyond just cost savings.

#GenericMedicines #AccessForAll